130 related articles for article (PubMed ID: 27762589)
1. HPMA copolymer-based polymer conjugates for the delivery and controlled release of retinoids.
Lidický O; Šírová M; Etrych T
Physiol Res; 2016 Oct; 65(Suppl 2):S233-S241. PubMed ID: 27762589
[TBL] [Abstract][Full Text] [Related]
2. HPMA copolymer conjugates of paclitaxel and docetaxel with pH-controlled drug release.
Etrych T; Sírová M; Starovoytova L; Ríhová B; Ulbrich K
Mol Pharm; 2010 Aug; 7(4):1015-26. PubMed ID: 20518512
[TBL] [Abstract][Full Text] [Related]
3. New HPMA copolymers containing doxorubicin bound via pH-sensitive linkage: synthesis and preliminary in vitro and in vivo biological properties.
Etrych T; Jelínková M; Ríhová B; Ulbrich K
J Control Release; 2001 May; 73(1):89-102. PubMed ID: 11337062
[TBL] [Abstract][Full Text] [Related]
4. HPMA copolymer conjugates with reduced anti-CD20 antibody for cell-specific drug targeting. I. Synthesis and in vitro evaluation of binding efficacy and cytostatic activity.
Etrych T; Strohalm J; Kovár L; Kabesová M; Ríhová B; Ulbrich K
J Control Release; 2009 Nov; 140(1):18-26. PubMed ID: 19632282
[TBL] [Abstract][Full Text] [Related]
5. HPMA-based polymer conjugates with drug combination.
Krakovicová H; Etrych T; Ulbrich K
Eur J Pharm Sci; 2009 Jun; 37(3-4):405-12. PubMed ID: 19491032
[TBL] [Abstract][Full Text] [Related]
6. Biodegradable star HPMA polymer conjugates of doxorubicin for passive tumor targeting.
Etrych T; Strohalm J; Chytil P; Černoch P; Starovoytova L; Pechar M; Ulbrich K
Eur J Pharm Sci; 2011 Apr; 42(5):527-39. PubMed ID: 21392579
[TBL] [Abstract][Full Text] [Related]
7. Biodegradable star HPMA polymer-drug conjugates: Biodegradability, distribution and anti-tumor efficacy.
Etrych T; Kovář L; Strohalm J; Chytil P; Ríhová B; Ulbrich K
J Control Release; 2011 Sep; 154(3):241-8. PubMed ID: 21699933
[TBL] [Abstract][Full Text] [Related]
8. Star structure of antibody-targeted HPMA copolymer-bound doxorubicin: a novel type of polymeric conjugate for targeted drug delivery with potent antitumor effect.
Kovár M; Strohalm J; Etrych T; Ulbrich K; Ríhová B
Bioconjug Chem; 2002; 13(2):206-15. PubMed ID: 11906257
[TBL] [Abstract][Full Text] [Related]
9. The pH-dependent and enzymatic release of cytarabine from hydrophilic polymer conjugates.
Pola R; Janoušková O; Etrych T
Physiol Res; 2016 Oct; 65(Suppl 2):S225-S232. PubMed ID: 27762588
[TBL] [Abstract][Full Text] [Related]
10. N-(2-hydroxypropyl)methacrylamide copolymer-6-(3-aminopropyl)-ellipticine conjugates. Synthesis, in vitro, and preliminary in vivo evaluation.
Searle F; Gac-Breton S; Keane R; Dimitrijevic S; Brocchini S; Sausville EA; Duncan R
Bioconjug Chem; 2001; 12(5):711-8. PubMed ID: 11562189
[TBL] [Abstract][Full Text] [Related]
11. HPMA Copolymer-Drug Conjugates with Controlled Tumor-Specific Drug Release.
Chytil P; Koziolová E; Etrych T; Ulbrich K
Macromol Biosci; 2018 Jan; 18(1):. PubMed ID: 28805040
[TBL] [Abstract][Full Text] [Related]
12. Properties of HPMA copolymer-doxorubicin conjugates with pH-controlled activation: effect of polymer chain modification.
Chytil P; Etrych T; Konák C; Sírová M; Mrkvan T; Ríhová B; Ulbrich K
J Control Release; 2006 Sep; 115(1):26-36. PubMed ID: 16899320
[TBL] [Abstract][Full Text] [Related]
13. Bloodstream Stability Predetermines the Antitumor Efficacy of Micellar Polymer-Doxorubicin Drug Conjugates with pH-Triggered Drug Release.
Chytil P; Šírová M; Kudláčová J; Říhová B; Ulbrich K; Etrych T
Mol Pharm; 2018 Sep; 15(9):3654-3663. PubMed ID: 29543465
[TBL] [Abstract][Full Text] [Related]
14. Highly effective anti-tumor nanomedicines based on HPMA copolymer conjugates with pirarubicin prepared by controlled RAFT polymerization.
Randárová E; Nakamura H; Islam R; Studenovský M; Mamoru H; Fang J; Chytil P; Etrych T
Acta Biomater; 2020 Apr; 106():256-266. PubMed ID: 32058082
[TBL] [Abstract][Full Text] [Related]
15. Designing polymer conjugates as lysosomotropic nanomedicines.
Duncan R
Biochem Soc Trans; 2007 Feb; 35(Pt 1):56-60. PubMed ID: 17233601
[TBL] [Abstract][Full Text] [Related]
16. Biodegradable Micellar HPMA-Based Polymer-Drug Conjugates with Betulinic Acid for Passive Tumor Targeting.
Lomkova EA; Chytil P; Janoušková O; Mueller T; Lucas H; Filippov SK; Trhlíková O; Aleshunin PA; Skorik YA; Ulbrich K; Etrych T
Biomacromolecules; 2016 Nov; 17(11):3493-3507. PubMed ID: 27636143
[TBL] [Abstract][Full Text] [Related]
17. HPMA copolymers with pH-controlled release of doxorubicin: in vitro cytotoxicity and in vivo antitumor activity.
Ulbrich K; Etrych T; Chytil P; Jelínková M; Ríhová B
J Control Release; 2003 Feb; 87(1-3):33-47. PubMed ID: 12618021
[TBL] [Abstract][Full Text] [Related]
18. Anticancer agents coupled to N-(2-hydroxypropyl)methacrylamide copolymers. I. Evaluation of daunomycin and puromycin conjugates in vitro.
Duncan R; Kopecková-Rejmanová P; Strohalm J; Hume I; Cable HC; Pohl J; Lloyd JB; Kopecek J
Br J Cancer; 1987 Feb; 55(2):165-74. PubMed ID: 3468994
[TBL] [Abstract][Full Text] [Related]
19. Overcoming multidrug resistance in Dox-resistant neuroblastoma cell lines via treatment with HPMA copolymer conjugates containing anthracyclines and P-gp inhibitors.
Koziolová E; Janoušková O; Cuchalová L; Hvězdová Z; Hraběta J; Eckschlager T; Sivák L; Ulbrich K; Etrych T; Šubr V
J Control Release; 2016 Jul; 233():136-46. PubMed ID: 27189135
[TBL] [Abstract][Full Text] [Related]
20. Novel star HPMA-based polymer conjugates for passive targeting to solid tumors.
Etrych T; Strohalm J; Chytil P; Říhová B; Ulbrich K
J Drug Target; 2011 Dec; 19(10):874-89. PubMed ID: 21978286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]